Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-21-020 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the development of enabling data science technologies to improve the acquisition, management, analysis, visualization, and dissemination of data and knowledge for immune-mediated and infectious diseases including disease mechanism, risk prediction, epidemiology, detection and diagnosis, treatment and vaccines across the allergy, immune-mediated, and infectious-disease research continuum, aligned with the research mission of NIAID. This includes infectiou...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 17, 2021 Category: Research Source Type: funding
All About Grants Podcast: Considerations for a Research Plan
Dr. Kentner Singleton, NIAID
Dr. Lillian Kuo, NCI
Thanks to a suggestion from a listener, in this NIH All About Grants episode (MP3 / Transcript) a duo of NIH program officers, Drs. Lillian Kuo from the National Cancer Institute and Kentner Singleton from the National Institute of Allergy and Infectious Diseases, share their advice and experience on developing a research plan for a grant application.
They discuss the relationship between the specific aims and research strategy, provide suggestions for when you sit down to start writing, and share common pitfalls. More helpful advice on writing your application is available...
Source: NIH Extramural Nexus - February 22, 2021 Category: Research Authors: NIH Staff Tags: New Resources podcast Research Strategy Specific Aims strategic plan Source Type: funding
Limited Competition: Facility and Building System Upgrades Support for the Regional Biocontainment Laboratories (G20 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-21-022 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to provide an opportunity for the Regional Biocontainment Laboratories (RBLs) established by the National Institute of Allergy and Infectious Diseases (NIAID) to request support for upgrades to existing facilities and building systems to facilitate the conduct of biomedical research on infectious diseases, including infectious disease outbreaks. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 19, 2021 Category: Research Source Type: funding
Human Immunology Project Consortium (HIPC) Coordinating Center (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-080 from the NIH Guide for Grants and Contracts. The goal of this FOA is to support a Coordinating Center for the Human Immunology Project Consortium (HIPC) program. The HIPC program, supported through a separate FOA, will consist of 5-8 multi-project cooperative agreement (U19) awardees that will measure the diversity and commonalities of human immune responses under a variety of conditions and longitudinally using high-throughput systems immunology approaches coupled with detailed clinical phenotyping in well-characterized human cohorts. The HIPC Coordinating Center supported by this FOA ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 8, 2021 Category: Research Source Type: funding
Human Immunology Project Consortium (U19 Clinical Trial Optional)
Funding Opportunity RFA-AI-20-079 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) for the Human Immunology Project Consortium (HIPC) solicits applications from single institutions, or consortia of institutions, to participate in a network of human immunology profiling research groups in the area of infectious diseases, including HIV. The purpose of this FOA is to characterize human immune responses/mechanisms elicited by vaccinations, vaccine adjuvants or natural infections by capitalizing on recent advances in immune profiling technologies. Studies supported under this FOA will ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 8, 2021 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Complement in Basic Immunology (CIBI)
Notice NOT-AI-21-008 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 4, 2021 Category: Research Source Type: funding
Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-078 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to support research to define the mechanisms regulating the establishment, development, and maintenance of immunity throughout childhood (from birth to less than 18 years of age), including the impact of pathogenic or non-pathogenic microbes or vaccination against infectious diseases, allergens, and environmental pollutants on immune ontogeny and function. This program will establish collaborations among immunologists, neonatologists, pediatricians, systems biologists, and microbiologist...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 12, 2021 Category: Research Source Type: funding
Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-077 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to support research to define the mechanisms regulating the establishment, development and maintenance of immunity throughout childhood (from birth to less than 18 years of age), including the impact of pathogenic or non-pathogenic microbes or vaccination against infectious diseases, allergens or environmental pollutants on immune ontogeny and function. This program will establish collaborations among immunologists, neonatologists, pediatricians, systems biologists, and microbiologists t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 12, 2021 Category: Research Source Type: funding
Aging Effects on Osteoimmunology (R01 Clinical Trials Not Allowed)
Funding Opportunity RFA-AG-22-002 from the NIH Guide for Grants and Contracts. This FOA seeks to support studies on normal and pathobiological changes in aging bone marrow that impact, or are impacted by, changes in immune function with age. Studies to be supported are in the field of osteoimmunology, which concerns the bidirectional interactions between bone and the immune system. The importance of osteoimmunology and its potential for improving the understanding of bone homeostasis is now recognized. However, most research has been conducted in young mice (3-4 months) that have not completed growth and development. Yo...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 10, 2020 Category: Research Source Type: funding
Understanding the Cellular and Molecular Mechanisms of Gastroparesis in Adults and Children (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-20-030 from the NIH Guide for Grants and Contracts. Since its establishment in 2006, the Gastroparesis Clinical Research Consortium (GpCRC), a multi-center coalition created and funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has made major advances to our understanding of the pathophysiology of gastroparesis (Gp) and develop an effective treatment for patients with symptomatic gastroparesis. Through the establishment of the largest gastroparesis tissue repository, combined with detailed phenotypic data, the GpCRC is ideally suited to accelerate insights...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 13, 2020 Category: Research Source Type: funding
A Multidisciplinary Approach to Study Vaccine-elicited Immunity and Efficacy against Malaria (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-064 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support research to advance understanding of the underlying immune mechanisms that contribute to malaria vaccine-elicited protection or vaccine hypo-responsiveness in endemic regions by capitalizing on recent research advances in systems vaccinology and systems immunology as well as emerging opportunities in data science and informatics. Multidisciplinary science and collaboration among investigators from the malaria vaccine research field and other relevant scientific areas are highly encouraged. The goal...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 7, 2020 Category: Research Source Type: funding
Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-291 from the NIH Guide for Grants and Contracts. The National Institute of Allergy and Infectious Diseases (NIAID) announces a program that provides NIAID-supported K01, K08, and K23 recipients with the opportunity to apply for Exploratory and Developmental Research Grant (R21) support at some point during the final two years of their K award. Through the use of this mechanism, NIAID seeks to enhance the capability of its K01, K08, and K23 award recipients to conduct research as they complete their transition to fully independent investigator status (e.g., R01 support). The R21 grant mechanism...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 14, 2020 Category: Research Source Type: funding
Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-290 from the NIH Guide for Grants and Contracts. The National Institute of Allergy and Infectious Diseases (NIAID) announces a program that provides NIAID-supported K01, K08, and K23 recipients with the opportunity to apply for Small Research Grant (R03) support at some point during the final two years of their K award. Through the use of this mechanism, NIAID seeks to enhance the capability of its K01, K08, and K23 award recipients to conduct research as they complete their transition to fully independent investigator status (e.g., R01 support). The R03 grant mechanism supports different type...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 14, 2020 Category: Research Source Type: funding
Institute and Center Award Rates and Funding Disparities
In 2011, Ginther et al. first demonstrated that African American and Black applicants to the National Institutes of Health received grant awards at a lower rate than their white counterparts (Ginther 2011). Since then, multiple studies have reproduced and extended this finding (Ginther 2011; Ginther 2016; Hoppe 2019; Erosheva 2020). Recently we reported that African American and Black (AAB) PIs are more likely to propose research on topics that are less likely to be funded (Hoppe 2019). We found that topic choice has little or no effect on whether an application is chosen for discussion, but after consideri...
Source: NIH Extramural Nexus - August 12, 2020 Category: Research Authors: Mike Lauer Tags: blog Open Mike Funding data Source Type: funding
Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-043 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications for an immunologic reagent resource to support and facilitate the optimal use of nonhuman primate (NHP) models for vaccine and adjuvant development, transplantation, and infectious and immune-mediated diseases. This resource will identify, obtain, develop, characterize, evaluate, produce, and distribute to the scientific community key immunologic reagents for NHP research that are not commercially available or, if commercially available, are not optimized for use in NHPs. In ad...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 29, 2020 Category: Research Source Type: funding
